Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Targeting The PRMT5 Enzyme To Induce γ -Globin Gene Derepression In Sickle Cell Anemia

Necrisha Roach, MSc., Matthew Cannon, Dalia El-Gamal, PhD, Payal C Desai, MD, Eric H. Kraut, MD, James E. Bradner, M.D., Rosa Lapalombella, PhD, Robert A. Baiocchi, M.D., Ph.D.

Blood (2013) 122 (21): 1007.

https://doi.org/10.1182/blood.V122.21.1007.1007

Published: 2013

Journal Articles

Silvestrol Modulates Indirect Anti-Tumor Activity and Potentiates Immune Response To Epstein-Barr Virus-Driven Lymphoproliferative Disease

John T. Patton, Alex S. Hartlage, Li Pan, PhD, Mark E Lustberg, MD, PhD, Callie M. Drohan, Marisa F. Martin, A. Douglas Kinghorn, Ph.D., D.Sc, Michael A. Caligiuri, MD, Michael R. Grever, MD, David M. Lucas, PhD, Robert A. Baiocchi, M.D., Ph.D.

Blood (2013) 122 (21): 4422.

https://doi.org/10.1182/blood.V122.21.4422.4422

Published: 2013

Journal Articles

Immune Reconstitution and Quality of Life Analyses After Autologous Transplant for Multiple Myeloma

Craig C. Hofmeister, MD, Mindy A Bowers, BS, Anissa Bingman, M.S., Gerard Lozanski, M.D., Robert A. Baiocchi, M.D., Ph.D., William Falk, B.S., Don M. Benson, Jr., MD, PhD, Yvonne A Efebera, M.D., Kristina Humphries, M.S., Megan Sell, RN, MS, Carli N Greenfield, RN, MSN, ACNP, Mark E Lustberg, MD, PhD, John L. Vaughn, BS, Christian Tyler Earl, Susan Geyer, PhD, Steven M. Devine, MD

Blood (2012) 120 (21): 4460.

https://doi.org/10.1182/blood.V120.21.4460.4460

Published: 2012

Journal Articles

Utilization of EBV DNA Copy Number Monitoring in Extranodal NK Lymphoma, Nasal Type in Non Asian Patients

Meng X Welliver, MD, PhD, Galena Salem, Amy S. Ruppert, MAS, Bradley A Otto, MD, Robert A. Baiocchi, M.D., Ph.D., Pierluigi Porcu, MD

Blood (2012) 120 (21): 5088.

https://doi.org/10.1182/blood.V120.21.5088.5088

Published: 2012

Journal Articles

Post Autologous Transplant Vorinostat (SAHA) in High Risk Lymphoma: Phase 1 Study of Vorinostat Maintenance

Craig C. Hofmeister, MD, Mindy A Bowers, BS, Robert A. Baiocchi, M.D., Ph.D., Gerard Lozanski, M.D., Kristina Humphries, M.S., Kristie A. Blum, MD, Pierluigi Porcu, MD, Sam Penza, MD, Carli N Greenfield, RN, MSN, ACNP, Megan Sell, RN, MS, Christian Tyler Earl, Joseph Zitesman, B.S., Carl Quinion, Mark E Lustberg, MD, PhD, Leslie A Andritsos, MD, Steven M. Devine, MD

Blood (2012) 120 (21): 2004.

https://doi.org/10.1182/blood.V120.21.2004.2004

Published: 2012

Journal Articles

Protein Arginine Methyltransferase 5 (PRMT5) Over-Expression Is Essential for Epstein-Barr Virus-Driven B-Cell Transformation.

Lapo Alinari, MD., Ph.D., Fengting Yan, M.D., Ph.D., Porsha Smith, John T. Patton, Carl Quinion, Bo Yu, Ph.D, Christian Tyler Earl, Mark E Lustberg, MD, PhD, Lynda Villagomez, Erin K Hertlein, PhD, John C. Byrd, MD, Leona Ayers, MD, Tasneem Motiwala, PhD, Sarmila Majumder, PhD, Chenglong Li, Ph.D., Said Sif, Ph.D., Samson T. Jacob, PhD, Robert A. Baiocchi, M.D., Ph.D.

Blood (2012) 120 (21): 2378.

https://doi.org/10.1182/blood.V120.21.2378.2378

Published: 2012

Journal Articles

Complex Karyotype (CK) Is Associated with a Shortened Progression-Free Survival (PFS) in Patients (pts) with Newly Diagnosed Mantle Cell Lymphoma (MCL).

Jonathon B. Cohen, MD, Amy S. Ruppert, MAS, Nyla A. Heerema, PhD, Jeffrey A. Jones, MD, MPH, Pierluigi Porcu, MD, Robert A. Baiocchi, M.D., Ph.D., Beth Christian, MD, John C. Byrd, MD, Joseph M. Flynn, DO, MPH, Sam Penza, MD, Leslie A Andritsos, MD, Steven M. Devine, MD, Kristie A. Blum, MD

Blood (2012) 120 (21): 2691.

https://doi.org/10.1182/blood.V120.21.2691.2691

Published: 2012

Journal Articles

Complete Response (CR) to Induction Therapy in Patients (pts) with Myc+ and Double Hit Non-Hodgkin's Lymphoma (NHL) Is Associated with Prolonged Progression-Free Survival (PFS).

Jonathon B. Cohen, MD, Susan Geyer, PhD, Gerard Lozanski, M.D., Weiqiang Zhao, MD PhD, Nyla A. Heerema, PhD, Jeffrey A. Jones, MD, MPH, Pierluigi Porcu, MD, Beth Christian, MD, Robert A. Baiocchi, M.D., Ph.D., Kami Maddocks, MD, Joseph M. Flynn, DO, MPH, Steven M. Devine, MD, Kristie A. Blum, MD

Blood (2012) 120 (21): 2693.

https://doi.org/10.1182/blood.V120.21.2693.2693

Published: 2012

Journal Articles

Phase I Study of AR-42 in Relapsed Multiple Myeloma and Lymphoma.

Craig C. Hofmeister, MD, Zhongfa Liu, Ph.D., Mindy A Bowers, BS, Pierluigi Porcu, MD, Joseph M. Flynn, DO, MPH, Beth Christian, MD, Robert A. Baiocchi, M.D., Ph.D., Don M. Benson, Jr., MD, PhD, Leslie A Andritsos, MD, Carli N Greenfield, RN, MSN, ACNP, Megan Sell, RN, MS, Susan Geyer, PhD, John C. Byrd, MD, Michael R. Grever, MD

Blood (2012) 120 (21): 2955.

https://doi.org/10.1182/blood.V120.21.2955.2955

Published: 2012

Journal Articles

Targeting the Cyclin D - CDK4/6 - Rb Axis in Mantle Cell Lymphoma with the Novel Translation Inhibitor Silvestrol,

Lapo Alinari, MD., Ph.D., Ryan B. Edwards, Courtney J. Prince, William H. Towns, Rajeswaran Mani, DVM, Amy Lehman, Xiaoli Zhang, PhD, MS, David Jarjoura, PhD, Li Pan, PhD, A. Douglas Kinghorn, PhD, DSc, Michael R. Grever, M.D., Robert A. Baiocchi, M.D., Ph.D., David M. Lucas, PhD

Blood (2011) 118 (21): 3498.

https://doi.org/10.1182/blood.V118.21.3498.3498

Published: 2011

Journal Articles

Results of A Phase I Study of Milatuzumab, a Humanized Anti-CD74 Antibody, and Veltuzumab, a Humanized Anti-CD20 Antibody, In Patients with Relapsed and Refractory B-Cell Non-Hodgkin's Lymphoma,

Beth Christian, MD, Lapo Alinari, MD., Ph.D., Jeffrey A. Jones, MD, MPH, Don M Benson, Jr., MD, PhD, Joseph M. Flynn, DO, MPH, Pierluigi Porcu, MD, Mark E Lustberg, MD, PhD, Mitchell Phelps, Ph.D., Ming Poi, PharmD, PhD, Diana Chung, BS, Carl Quinion, John C. Byrd, MD, William Wegener, MD, PhD, David M Goldenberg, Robert A. Baiocchi, M.D., Ph.D., Kristie A. Blum, MD

Blood (2011) 118 (21): 3707.

https://doi.org/10.1182/blood.V118.21.3707.3707

Published: 2011

Journal Articles

Silvestrol Modulates Direct Anti-Tumor Activity Against Epstein-Barr Virus (EBV)-Associated Lymphomas While Sparing Innate and Antigen Specific Adaptive Immunity

John T. Patton, Mark E Lustberg, MD, PhD, Sabrina L Garman, A Douglas Kinghorn, Ph.D., D.Sc, Li Pan, PhD, David M. Lucas, PhD, Michael R. Grever, M.D., Robert A. Baiocchi, M.D., Ph.D.

Blood (2011) 118 (21): 104.

https://doi.org/10.1182/blood.V118.21.104.104

Published: 2011

Journal Articles

Successful Treatment of Primary Central Nervous System Post-Transplant Lymphoproliferative Disorder (PCNS-PTLD) with Zidovudine (AZT), Ganciclovir (GCV), Rituximab and Dexamethasone: A Single-Institution Case Series

Ludmila Katherine Martin, MD, Mark E Lustberg, MD, PhD, Fengting Yan, M.D., Ph.D., John T. Patton, Pierluigi Porcu, MD, Gerard Nuovo, M.D., Robert Cavaliere, MD, Robert A. Baiocchi, M.D., Ph.D.

Blood (2011) 118 (21): 3067.

https://doi.org/10.1182/blood.V118.21.3067.3067

Published: 2011

Journal Articles

The Prognostic Value of FDG PET/CT Prior to Autologous Stem Cell Transplant in Mantle Cell Lymphoma

Jonathon B. Cohen, MD, Nathan Hall, MD, PhD, Amy S. Ruppert, MAS, Jeffrey A. Jones, MD, MPH, Pierluigi Porcu, MD, Robert A. Baiocchi, M.D., Ph.D., Sam Penza, MD, Don M Benson, Jr., MD, PhD, Leslie A Andritsos, MD, Joseph M. Flynn, DO, MPH, Steven M. Devine, MD, Kristie A Blum, MD

Blood (2011) 118 (21): 3113.

https://doi.org/10.1182/blood.V118.21.3113.3113

Published: 2011

Journal Articles

Risk Factors for Post-Transplant Lymphoproliferative Disorder in Solid Organ Transplant Recipients

Mark E Lustberg, MD, PhD, Ronald Pelletier, MD, Pierluigi Porcu, MD, Stanley Martin, MD, Robert A. Baiocchi, M.D., Ph.D.

Blood (2011) 118 (21): 4465.

https://doi.org/10.1182/blood.V118.21.4465.4465

Published: 2011

Journal Articles

Developing a Novel Class of Drug to Inhibit Protein Arginine Methyltransferase 5 (PRMT5) Enzyme Dysregulation in Mantle Cell Lymphoma

Fengting Yan, M.D., Ph.D., Porsha Smith, Lapo Alinari, MD., Ph.D., John Ryu, Bo Yu, Ph.D., Vrajesh Karkhanis, Ph.D., Sookil Tae, Ph.D., John T. Patton, Emily E. Wilding, Kate Gordon, Kiran Mahasenan, Ph.D., Deepak Bhasin, Ph.D., Claudio Agostinelli, M.D., Ph.D., Stefano A. Pileri, M.D., John C. Byrd, MD, Said Sif, Ph.D., Pui-kai Li, Ph.D., Chenglong Li, Ph.D., Robert A. Baiocchi, M.D., Ph.D.

Blood (2011) 118 (21): 595.

https://doi.org/10.1182/blood.V118.21.595.595

Published: 2011

Journal Articles

FTY720 Increases CD74 Expression and Sensitizes Mantle Cell Lymphoma Cells to Milatuzumab-Mediated Cell Death

Lapo Alinari, MD., Ph.D., Emilia Mahoney, MD, PhD, John T. Patton, Xiaoli Zhang, PhD, MS, Lenguyen Huynh, Christian Tyler Earl, Rajeswaran Mani, DVM, Yicheng Mao, Bo Yu, Ph.D., William H. Towns, Ching-Shih Chen, Ph.D, David M. Goldenberg, Kristie A. Blum, MD, John C. Byrd, MD, Natarajan Muthusamy, DVM, Ph.D, Mette Ibba, PhD, Robert A. Baiocchi, M.D., Ph.D.

Blood (2011) 118 (21): 600.

https://doi.org/10.1182/blood.V118.21.600.600

Published: 2011

NARROW

Targeting The PRMT5 Enzyme To Induce γ -Globin Gene Derepression In Sickle Cell Anemia

Silvestrol Modulates Indirect Anti-Tumor Activity and Potentiates Immune Response To Epstein-Barr Virus-Driven Lymphoproliferative Disease

Immune Reconstitution and Quality of Life Analyses After Autologous Transplant for Multiple Myeloma

Utilization of EBV DNA Copy Number Monitoring in Extranodal NK Lymphoma, Nasal Type in Non Asian Patients

Post Autologous Transplant Vorinostat (SAHA) in High Risk Lymphoma: Phase 1 Study of Vorinostat Maintenance

Protein Arginine Methyltransferase 5 (PRMT5) Over-Expression Is Essential for Epstein-Barr Virus-Driven B-Cell Transformation.

Complex Karyotype (CK) Is Associated with a Shortened Progression-Free Survival (PFS) in Patients (pts) with Newly Diagnosed Mantle Cell Lymphoma (MCL).

Complete Response (CR) to Induction Therapy in Patients (pts) with Myc+ and Double Hit Non-Hodgkin's Lymphoma (NHL) Is Associated with Prolonged Progression-Free Survival (PFS).

Phase I Study of AR-42 in Relapsed Multiple Myeloma and Lymphoma.

Targeting the Cyclin D - CDK4/6 - Rb Axis in Mantle Cell Lymphoma with the Novel Translation Inhibitor Silvestrol,

Results of A Phase I Study of Milatuzumab, a Humanized Anti-CD74 Antibody, and Veltuzumab, a Humanized Anti-CD20 Antibody, In Patients with Relapsed and Refractory B-Cell Non-Hodgkin's Lymphoma,

Silvestrol Modulates Direct Anti-Tumor Activity Against Epstein-Barr Virus (EBV)-Associated Lymphomas While Sparing Innate and Antigen Specific Adaptive Immunity

Successful Treatment of Primary Central Nervous System Post-Transplant Lymphoproliferative Disorder (PCNS-PTLD) with Zidovudine (AZT), Ganciclovir (GCV), Rituximab and Dexamethasone: A Single-Institution Case Series

The Prognostic Value of FDG PET/CT Prior to Autologous Stem Cell Transplant in Mantle Cell Lymphoma

Risk Factors for Post-Transplant Lymphoproliferative Disorder in Solid Organ Transplant Recipients

Developing a Novel Class of Drug to Inhibit Protein Arginine Methyltransferase 5 (PRMT5) Enzyme Dysregulation in Mantle Cell Lymphoma

FTY720 Increases CD74 Expression and Sensitizes Mantle Cell Lymphoma Cells to Milatuzumab-Mediated Cell Death

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only